2025 third_quarter Filing
Q3Lobbying Activities
Support inclusion of community project funding and congressional project spending in HR 5304 and S 2587 legislation and explanatory statements; support extension of tax credits for marketplace premiums under Affordable Care Act; advocacy for reversal in whole or part of Medicaid cuts in HR1 Budget Reconciliation Act; oppose administrative rule change to move340(b) prescription drug pricing program to rebate model
Support inclusion of community project funding and congressional project spending in HR 5304 and S 2587 legislation and explanatory statements; support extension of tax credits for marketplace premiums under Affordable Care Act; advocacy for reversal in whole or part of Medicaid cuts in HR1 Budget Reconciliation Act; oppose administrative rule change to move340(b) prescription drug pricing program to rebate model